ARTICLE | Company News
Chugai, Taisho Pharmaceutical Holdings, Roche sales and marketing update
May 2, 2016 7:00 AM UTC
Chugai and Taisho launched a monthly oral formulation of Boniva ibandronate in Japan to treat osteoporosis. The National Health Insurance (NHI) price of a 100 mg tablet, the recommended monthly dose,...